First Tracks Biotherapeutics, Inc. (TRAX)
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
First Tracks Biotherapeutics Inc
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 35.73M shares outstanding
USFirst Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments.
The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Leadership
Daniel R. Faga
CEO, President & Director
Paul F. Lizzul FAAD
Chief Medical Officer
Ajim A. Tamboli
Chief Financial Officer
Benjamin Stone
Chief Business Officer
Employees
104
Country
US
Sector
Healthcare
Website
firsttracksbio.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Orwin John A | Director | Option Exercise | 1.3K | -- | Sep 15, 2026 |
| Orwin John A | Director | Option Exercise | 1.3K | -- | Sep 15, 2026 |
 Ware J. Anthony | Director | Option Exercise | 28.6K | -- | Sep 2, 2026 |
| Ware J. Anthony | Director | Sale | 39.3K | $1.76M | Sep 2, 2026 |
| Ware J. Anthony | Director | Option Exercise | 39.3K | $225.4K | Sep 2, 2026 |
| Ware J. Anthony | Director | Option Exercise | 10.7K | -- | Sep 2, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
EcoR1 Capital, LLC | 3.2M | 8.9% | 13F |
EcoR1 Capital, LLC · also on 13F· may incl. warrants· filed Apr 2026 | 3.2M | 8.9% | 13G |
TCG Crossover Management, LLC | 2.9M | 8.1% | 13F |
FMR LLC | 2.1M | 5.7% | 13F |
Affinity Asset Advisors, LLC | 2.0M | 5.7% | 13F |
BlackRock, Inc. | 2.0M | 5.5% | 13F |
Trails Edge Capital Partners, LP | 1.5M | 4.2% | 13F |
STATE STREET CORP | 1.5M | 4.2% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | 4.1% | 13F |
Jupiter Topco LLC | 1.1M | 3.1% | 13F |
Insiders
- Orwin John ADirector
- Ware J. AnthonyDirector
- STONE BENJAMINChief Business Officer
- Lizzul Paul F.Chief Medical Officer
- Faga DanielPresident, CEO
- Jain RitaDirector
- FENTON DENNIS MDirector
- Schmid John P.Director
- Marquet MagdaDirector
- Tamboli AjimChief Financial Officer
based on 35.73M shares outstanding
US30d Avg
1.23M
60d Avg
965.96K
90d Avg
847.20K